Westport, CT, Nov. 13, 2023 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. BSGM (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 6,996,922 shares…Read More
BioSig Announces 25 Million Registered Direct Offering Priced AttheMarket Under Nasdaq Rules BioSig Technologies NASDAQBSGM
